|
|
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
Pall Corporation has purchased GeneSystems, a privately held French biotechnology company that has developed a unique, easy-to-use and cost-effective molecular diagnostics platform. The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pallīs Total Fluid ManagementSM (TFM) capabilities in the $1 billion biopharmaceuticals process monitoring market. The acquisition also presents Pall with new opportunities in its environmental, food and beverage and water markets.
Founded in 2000 in Bruz, France, GeneSystems quickly gained market recognition for its quantitative Legionella diagnostic platform. Since its first product arrived on the market in 2004, GeneSystems has developed systems for the rapid and precise diagnosis of a range of pathogens, including food safety testing focused on E. coli. These proven systems employ advanced sample preparation methods and real-time PCR technology to enable fast and high throughput along with high reproducibility analysis of multiple DNA targets. | |
Source: Pall Life Sciences
Posted: September 23, 2008
|
|
|
|
